1. Home
  2. CCEL vs TELA Comparison

CCEL vs TELA Comparison

Compare CCEL & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$4.51

Market Cap

32.7M

Sector

Health Care

ML Signal

N/A

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

HOLD

Current Price

$0.99

Market Cap

31.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCEL
TELA
Founded
1989
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
31.4M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
CCEL
TELA
Price
$4.51
$0.99
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $2.08
AVG Volume (30 Days)
9.9K
★ 139.6K
Earning Date
10-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 37.59
EPS
★ 0.23
N/A
Revenue
$25,384,279.00
★ $80,275,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.24
P/E Ratio
$19.04
★ N/A
Revenue Growth
9.76
★ 15.84
52 Week Low
$2.72
$0.50
52 Week High
$4.90
$1.51

Technical Indicators

Market Signals
Indicator
CCEL
TELA
Relative Strength Index (RSI) 53.80 43.13
Support Level $3.19 $0.61
Resistance Level $4.76 $0.97
Average True Range (ATR) 0.46 0.12
MACD 0.04 -0.02
Stochastic Oscillator 70.41 11.57

Price Performance

Historical Comparison
CCEL
TELA

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: